Spectrum Pharmaceuticals Shares Quiet; Co Releases Poster Titled 'Interim safety evaluation of same-day dosing of eflapegrastim* in patients with early-stage breast cancer (ESBC) receiving docetaxel and cyclophosphamide (TC)'